Search Results

Advanced Brain Monitoring, Inc. today announced integration of its mobile, wireless 24-channel EEG system with the Stratus EEG cloud-based clinical software platform for home or hospital seizure monitoring.

Stratus® Medical, a company focused on improving clinical outcomes for chronic pain patients by advancing radiofrequency (RF) technology for the treatment of pain, announced today the issuance of its fifth U.S. patent (U.S. Patent No. 11,806,070) and first two Canadian patents (Canadian Patent Nos. 2,778,997 and 2,799,505) for the NIMBUS® Electrosurgical RF Multitined Expandable Electrode (“NIMBUS”).

Stratus® Medical and the University of Utah, Department of Physical Medicine and Rehabilitation, announced the first patient enrolled in the COBRA study, a double-blinded, randomized trial, comparing the bipolar treatment with Nimbus® RF Multitined Expandable Electrode to conventional radiofrequency ablation for the treatment of sacroiliac joint pain.

Adam Clarke, CEO and Principal Consultant of Stratus commented, “The projects that Nirvana Life Sciences are advancing represent the evolution of modern medicine.

Beacon Biosignals, which applies AI to EEG to unlock precision medicine for brain conditions, today announced a partnership with Stratus, the nation’s leading provider of EEG services, to enable expanded clinical trial service capabilities by leveraging Beacon’s machine learning neuroanalytics platform.

Stratus™ Medical, a company focused on advancing radiofrequency (RF) ablation treatment for chronic pain, announced three new patents today.

The November layoffs are the second known workforce reduction this year for Marinus Pharmaceuticals, which previously announced disappointing Phase III results for ganaxolone in two clinical trials.

NeuroX, an online Neurology and Psychology clinic, and Stratus, the leader in home EEG testing, today announced that Stratus will partner with NeuroX to provide in-home video electroencephalogram (EEG) diagnostics